Knowledge of disease and access to a specialist reported by Spanish patients with ulcerative colitis: UC-LIFE survey

by Federico Argüelles-Arias, Daniel Carpio, Xavier Calvet, Cristina Romero, Luis Cea-Calvo, Berta Juliá, Antonio López-Sanromán

Fecal microbiota transplantation: something more than merely a therapeutic curiosity

by Carlos Ferre-Aracil, Lara Aguilera-Castro, Enrique Rodríguez-de-Santiago, Ana García-García-de-Paredes, Antonio López-Sanromán
Published 2015-07-01

What is the real-life maintenance mesalazine dose in ulcerative colitis?

by Alicia Algaba, Iván Guerra, Ana García-García-de-Paredes, María Hernández-Tejero, Carlos Ferre, Daniel Bonillo, Lara Aguilera, Antonio López-Sanromán, Fernando Bermejo

Mercaptopurine and inflammatory bowel disease: the other thiopurine

by Fernando Bermejo, Alicia Algaba, Sergio López-Durán, Iván Guerra, Marta Aicart-Ramos, María Hernández-Tejero, Elena Garrido, María de-Lucas, Daniel Bonillo, Antonio López-Sanromán

Response to Infliximab in Crohn’s Disease: Genetic Analysis Supporting Expression Profile

by Luz María Medrano, Carlos Taxonera, Cristina González-Artacho, Virginia Pascual, María Gómez-García, Manuel Barreiro-de Acosta, José L. Pérez-Calle, Fernando Bermejo, Antonio López-Sanromán, Dolores Martín Arranz, Javier P. Gisbert, Juan Luis Mendoza, Javier Martín, Concepción Núñez, Elena Urcelay
Published 2015-01-01

An Immunologic Compatibility Testing Was Not Useful for Donor Selection in Fecal Microbiota Transplantation for Ulcerative Colitis

by Manuel Ponce-Alonso, Manuel Ponce-Alonso, Carlota García-Hoz, Ana Halperin, Ana Halperin, Javier Nuño, Pilar Nicolás, Adolfo Martínez-Pérez, Juan Ocaña, Juan Carlos García-Pérez, Antonio Guerrero, Antonio López-Sanromán, Rafael Cantón, Rafael Cantón, Garbiñe Roy, Rosa del Campo, Rosa del Campo, Rosa del Campo
Published 2021-06-01